Published in Trends Microbiol on November 19, 2013
Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog (2014) 1.35
Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology (2015) 0.86
The VP4 peptide of hepatitis A virus ruptures membranes through formation of discrete pores. J Virol (2014) 0.82
Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses. J Virol (2016) 0.82
SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitis. PLoS One (2014) 0.79
Role of Envelopment in the HEV Life Cycle. Viruses (2016) 0.78
Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope. PLoS One (2015) 0.78
Specific IgA Enhances the Transcytosis and Excretion of Hepatitis A Virus. Sci Rep (2016) 0.77
Causation by HEV of extrahepatic manifestations remains unproven. Liver Int (2016) 0.76
Hepatitis E Pathogenesis. Viruses (2016) 0.75
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med (2001) 8.38
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet (2010) 7.11
Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology (1991) 6.38
Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Crit Rev Biochem Mol Biol (1993) 6.36
Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med (2007) 5.87
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
Hepatitis E: an emerging awareness of an old disease. J Hepatol (2008) 4.84
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med (2007) 4.69
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med (1992) 4.05
A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature (2013) 3.55
Hepatitis E virus. Rev Med Virol (2003) 3.34
Type A viral hepatitis. New developments in an old disease. N Engl J Med (1985) 2.86
Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology (2007) 2.68
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A (1987) 2.56
Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A (2007) 2.38
The ESCRT complexes. Crit Rev Biochem Mol Biol (2010) 2.23
Apical trafficking in epithelial cells: signals, clusters and motors. J Cell Sci (2009) 2.08
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology (2011) 2.01
Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures. J Clin Microbiol (1984) 1.61
Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. J Virol (2008) 1.49
Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J Virol (1999) 1.49
Role of microtubules in extracellular release of poliovirus. J Virol (2009) 1.49
Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol (1990) 1.44
ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J Gen Virol (2009) 1.41
Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci U S A (2011) 1.36
Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol (2010) 1.28
Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus). J Med Virol (1995) 1.28
Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog (2011) 1.18
Canalicular ABC transporters and liver disease. J Pathol (2012) 1.15
Serum neutralizing antibody response to hepatitis A virus. J Infect Dis (1983) 1.15
Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol (1999) 1.15
Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol (2008) 1.10
Review of the neurological manifestations of hepatitis E infection. Ann Hepatol (2012) 1.08
Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation. Traffic (2011) 1.08
A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J Gen Virol (2010) 0.99
Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol (2010) 0.99
Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J Gen Virol (2011) 0.93
Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch Virol (2008) 0.92
Non-A, non-B epidemic hepatitis: visualization of virus-like particles in the stool by immune electron microscopy. J Gen Virol (1984) 0.92
Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase. J Virol (1999) 0.92
Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulin. J Infect Dis (1997) 0.86